- Medical and pharmaceutical products reached exports worth US$966.0 million.
The National Council of Free Export Zones (CNZFE) reported that exports from the sector reached US$2,803.3 million during the January-April 2026 period.
This amount represents a year-on-year growth of 4.3% and an absolute increase of US$115.2 million compared to the same period in 2025.
The sector’s performance was driven by strategic segments with high added value, such as medical and pharmaceutical products, which reached exports of US$966.0 million, followed by tobacco and its derivatives with US$461.2 million, and electrical and electronic products with US$415.2 million.
In terms of growth, these latter sectors showed significant expansions, evidencing the strengthening of the country’s industrial base and its ability to insert itself into sophisticated and demanding markets.
Likewise, a sustained process of productive diversification has been seen, with outstanding growth in activities such as metals and their manufactures (62.5%), marketing (23.2%), and chemical products (20.6%).
Source:
